Condensed Interim Consolidated Statements of Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Service revenue	$ 18,012,190	$ 19,304,461
Expenses:
Direct center and patient care costs	13,158,183	13,758,220
Other regional and center support costs (note 24)	7,032,567	5,078,698
Depreciation (notes 5 and 7(a))	313,240	965,048
Total	20,503,990	19,801,966
Regional operating loss	(2,491,800)	(497,505)
Center development costs	124,444	112,191
Corporate, general and administrative expenses (note 24)	7,679,714	7,278,571
Share-based compensation (note 15)	25,302	62,948
Amortization (note 6)	16,548	16,548
Interest expense	4,202,402	2,692,418
Interest income	(65)	(45)
Loss before income taxes	(14,540,145)	(10,660,136)
Income tax expense (note 18)	0	0
Loss for the year and comprehensive loss	(14,540,145)	(10,660,136)
Non-controlling interest (note 23)	(321,849)	(68,826)
Loss for the year and comprehensive loss attributable to Greenbrook	$ (14,218,296)	$ (10,591,310)
Net loss per share (note 22):
Basic	$ (0.32)	$ (0.34)
Diluted	$ (0.32)	$ (0.34)